U.S. Healthy high growth potential

Axsome Therapeutics

Market Cap: US$5.7b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Infinity Natural Resources

Market Cap: US$829.1m

Engages in the acquisition, exploration, and development of properties to produce oil, natural gas, and natural gas liquids from underground reservoirs in the United States.

Alnylam Pharmaceuticals

Market Cap: US$60.5b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Travere Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Credo Technology Group Holding

Market Cap: US$28.4b

Provides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.

TG Therapeutics

Market Cap: US$4.7b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Alkami Technology

Market Cap: US$2.7b

Provides cloud-based digital banking solutions in the United States.

Zevra Therapeutics

Market Cap: US$407.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

NVIDIA

Market Cap: US$4.1t

A computing infrastructure company, provides graphics and compute and networking solutions in the United States, Singapore, Taiwan, China, Hong Kong, and internationally.

Hesai Group

Market Cap: US$4.4b

Through with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.

Caris Life Sciences

Market Cap: US$9.5b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Hippo Holdings

Market Cap: US$931.3m

Provides property and casualty insurance products to individuals and business customers primarily in the United States.

FTC Solar

Market Cap: US$103.1m

Engages in the manufacture and service of solar tracker systems in the United States, Asia, Europe, the Middle East, North Africa, South Africa, and Australia.

Atour Lifestyle Holdings

Market Cap: US$5.4b

Through its subsidiaries, develops lifestyle brands around hotel offerings in the People’s Republic of China.

Nu Holdings

Market Cap: US$76.8b

Provides digital banking platform in Brazil, Mexico, Colombia, the Cayman Islands, and the United States.

Upstart Holdings

Market Cap: US$6.5b

Operates a cloud-based artificial intelligence (AI) lending platform in the United States.

Broadcom

Market Cap: US$1.7t

Designs, develops, and supplies various semiconductor devices and infrastructure software solutions worldwide.

Astera Labs

Market Cap: US$39.7b

Designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.

Shift4 Payments

Market Cap: US$7.6b

Engages in the provision of software and payment processing solutions in the United States and internationally.

Mereo BioPharma Group

Market Cap: US$280.0m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Niu Technologies

Market Cap: US$322.0m

Designs, manufactures, and sells electric scooters in the People's Republic of China, Europe, and internationally.

IREN

Market Cap: US$9.9b

Operates in the vertically integrated data center business.

Oracle

Market Cap: US$871.4b

Offers products and services that address enterprise information technology environments worldwide.

Legend Biotech

Market Cap: US$6.3b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Cloudflare

Market Cap: US$76.4b

Operates as a cloud services provider that delivers a range of services to businesses worldwide.

DLocal

Market Cap: US$4.3b

Operates a payment processing platform worldwide.

Palantir Technologies

Market Cap: US$399.3b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

AST SpaceMobile

Market Cap: US$14.5b

Designs and develops the constellation of BlueBird satellites in the United States.

Capricor Therapeutics

Market Cap: US$284.4m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Soleno Therapeutics

Market Cap: US$2.6b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Renasant

Market Cap: US$3.6b

Operates as a bank holding company for Renasant Bank that provides a range of financial, wealth management, fiduciary, and insurance services to retail and commercial customers.

Achieve Life Sciences

Market Cap: US$157.4m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

RenovoRx

Market Cap: US$46.2m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Excelerate Energy

Market Cap: US$2.7b

Provides liquefied natural gas (LNG) solutions worldwide.

Abeona Therapeutics

Market Cap: US$291.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

OS Therapies

Market Cap: US$70.3m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.